Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Advanced Course on Deep Dive in CDK4-6 Inhibitors Data in Breast Cancer 2023: Dubai

Session 3 - Research or rational combinations of CDK4-6 inhibitors with targeted agents

Role of CD 4-6 inhibitors across enriched molecular subgroup

Date

20 May 2023

Session

Session 3 - Research or rational combinations of CDK4-6 inhibitors with targeted agents

Topics

Pathology/Molecular Biology;  Targeted Therapy

Tumour Site

Breast Cancer

Presenters

A. Bosch, SE

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.